The complex genomic profile of ETV6‐RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1
暂无分享,去创建一个
Andrew G. Hall | F. Ross | C. Harrison | A. Moorman | M. Griffiths | J. Irving | J. Strefford | Z. Konn | M. Case | K. Barber | H. Parker | A. Stewart | S. Wright | Q. An | Teresa Davies | Kerry E. Barber
[1] Cun-Yu Wang,et al. TBL1–TBLR1 and β-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis , 2008, Nature Cell Biology.
[2] C. Moon,et al. Epigenetic silencing of human T (brachyury homologue) gene in non-small-cell lung cancer. , 2008, Biochemical and biophysical research communications.
[3] P. Pandolfi,et al. RARα-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia , 2007, Proceedings of the National Academy of Sciences.
[4] B. Nilsson,et al. Combined high-resolution array-based comparative genomic hybridization and expression profiling of ETV6/RUNX1-positive acute lymphoblastic leukemias reveal a high incidence of cryptic Xq duplications and identify several putative target genes within the commonly gained region , 2007, Leukemia.
[5] J. Inazawa,et al. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma , 2007, Oncogene.
[6] F. Ross,et al. Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization , 2007, Oncogene.
[7] Carl W. Miller,et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. , 2007, Blood.
[8] J. Hehir-Kwa,et al. High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression , 2007, Leukemia.
[9] Christopher B. Miller,et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.
[10] F. Jardin,et al. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas , 2007, Leukemia.
[11] K Fenwick,et al. Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse , 2006, The Journal of pathology.
[12] Stuart Brown,et al. TBLR1 regulates the expression of nuclear hormone receptor co-repressors , 2006, BMC Cell Biology.
[13] T. Richmond,et al. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[14] R. Roeder,et al. Thyroid hormone-induced juxtaposition of regulatory elements/factors and chromatin remodeling of Crabp1 dependent on MED1/TRAP220. , 2005, Molecular cell.
[15] S. Bohlander. ETV6: a versatile player in leukemogenesis. , 2005, Seminars in cancer biology.
[16] C. Steidl,et al. Distinct Gene Expression Pattern of Malignant Hematopoietic Stem and Progenitor Cells in Polycythemia Vera , 2005, Annals of the New York Academy of Sciences.
[17] F. Ross,et al. Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study , 2005, British journal of haematology.
[18] L. Feuk,et al. Detection of large-scale variation in the human genome , 2004, Nature Genetics.
[19] Kenny Q. Ye,et al. Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.
[20] Ana-Teresa Maia,et al. Protracted postnatal natural histories in childhood leukemia , 2004, Genes, chromosomes & cancer.
[21] C. Glass,et al. A Corepressor/Coactivator Exchange Complex Required for Transcriptional Activation by Nuclear Receptors and Other Regulated Transcription Factors , 2004, Cell.
[22] Jun Qin,et al. Purification and functional characterization of the human N‐CoR complex: the roles of HDAC3, TBL1 and TBLR1 , 2003, The EMBO journal.
[23] M. Zahurak,et al. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. , 2002, Cancer research.
[24] M. Greaves,et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] H. Prentice,et al. ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia , 2002, Leukemia.
[26] Brian T Chait,et al. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. , 2002, Molecular cell.
[27] J. Aster,et al. The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. , 2001, Cancer genetics and cytogenetics.
[28] M. Greaves,et al. Prenatal origin of acute lymphoblastic leukaemia in children , 1999, The Lancet.
[29] J. Rowley. The role of chromosome translocations in leukemogenesis. , 1999, Seminars in hematology.
[30] M. Greaves,et al. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. , 1999, Blood.
[31] Jianxiang Wang,et al. Nuclear receptor co‐repressor gene localizes to 17p11.2, a frequently deleted band in malignant disorders , 1999, Genes, chromosomes & cancer.
[32] T. Hoshino,et al. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] L. Chin,et al. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression , 1997, nature.
[34] J. Downing,et al. TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] J. Rowley,et al. Correlation between the ETV6/CBFA2 (TEL/AMLI) fusion gene and karyotypic abnormalities in children with B‐cell precursor acute lymphoblastic leukemia , 1996, Genes, chromosomes & cancer.
[36] J. Cayuela,et al. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. , 1996, Leukemia.
[37] S. Shurtleff,et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. , 1995, Leukemia.
[38] D. Le Paslier,et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. , 1995, Blood.
[39] D C Ward,et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[40] R. Berger,et al. t( 12;21): A new recurrent translocation in acute lymphoblastic leukemia , 1994, Genes, chromosomes & cancer.
[41] P. Fenaux,et al. Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. , 1993, Blood.
[42] L. Gudas,et al. The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. , 1992, The Journal of biological chemistry.
[43] C. Chomienne,et al. Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. , 1992, Cancer research.
[44] A. Dejean,et al. Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes. , 1989, The EMBO journal.
[45] C. Harrison,et al. Disruption of ETV6 in intron 2 results in upregulatory and insertional events in childhood acute lymphoblastic leukaemia , 2008, Leukemia.